Eli Lilly and Company (LLY)
Eli Lilly is acquiring Orna Therapeutics for up to $2.4 billion, expanding its pipeline beyond its successful weight loss drug Zepbound. The company also reported strong Q4 earnings, surpassing estimates due to high demand for its weight loss and diabetes drugs.
About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical corporation focused on developing and manufacturing medicines.
Eli Lilly and Company uses the ticker $LLY for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Eli Lilly and Company (LLY) sentiment is up 17.14% from the previous week.
Price: $1,040
Price 24-Hour Time-Series Raw Data
Eli Lilly's stock is experiencing an upward trend, hitting a 52-week and all-time high, supported by strong drug performance in the weight loss sector and AI partnerships, despite ongoing competition and pricing discussions.
24-Hour: 0% 7-Day: -3.85% 30-Day: 0.15%
1-Year High: $1,109.90 on 2025-11-25
1-Year Low: $625.70 on 2025-08-08
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Eli Lilly and Company (LLY) is currently AltRank #445 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +13
[--] Month: [---] +32
[--] Months: [---] +19
[--] Year: [---] +72
1-Year High: [-----] on 2025-03-08
1-Year Low: [--] on 2025-08-13
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +7
[--] Months: [--] +5
[--] Year: [--] +13
1-Year High: [--] on 2025-03-24
1-Year Low: [--] on 2025-04-03
Engagements: [-------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [---------]
[--] Week: [---------] -40%
[--] Month: [----------] -2.60%
[--] Months: [-----------] +116%
[--] Year: [-----------] +83%
1-Year High: [----------] on 2025-11-11
1-Year Low: [-------] on 2025-03-16
Engagements by network (24h): Reddit: [---] X: [-------] YouTube: [------] Instagram: [---] TikTok: [------] News: [------]
Mentions: [-----] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] -11%
[--] Month: [------] +38%
[--] Months: [-------] +22%
[--] Year: [-------] +115%
1-Year High: [-----] on 2025-07-08
1-Year Low: [---] on 2025-12-07
Mentions by network (24h): Reddit: [--] X: [-----] YouTube: [---] Instagram: [--] TikTok: [---] News: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Eli Lilly and Company (LLY) in the last [--] hours which is down 5.40% from [-----] in the previous [--] hours
Daily Average: [-----]
[--] Week: [-----] -14%
[--] Month: [-----] +45%
[--] Months: [------] +11%
[--] Year: [------] +290%
1-Year High: [-----] on 2025-07-08
1-Year Low: [---] on 2025-03-16
The most influential creators that mention Eli Lilly and Company in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @EliLillyandCo | [--] | [-------] | [--] | [------] |
| @BioStocks | [--] | [------] | [--] | [------] |
| @investseekers | [--] | [-----] | [--] | [------] |
| @JKeynesAlpha | [--] | [------] | [--] | [-----] |
| @PersimmonTI | [--] | [------] | [--] | [-----] |
| @semodough | [--] | [-----] | [--] | [-----] |
| @CNBCtelevision | [--] | [---------] | [--] | [-----] |
| @seeinggrace | [--] | [-----] | [--] | [-----] |
| @ManOnThePen | [--] | [-----] | [--] | [-----] |
| @Chartfest1 | [--] | [-----] | [--] | [-----] |
Sentiment: 81%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 81%
Daily Average: 74%
[--] Week: 82% +12%
[--] Month: 75% -3%
[--] Months: 75% +13%
[--] Year: 75% +5%
1-Year High: 96% on 2025-07-08
1-Year Low: 8% on 2025-12-15
Most Supportive Themes:
- Weight Loss Drug Success: (50%) Eli Lilly's Mounjaro and Zepbound are experiencing high demand, with potential for oral formulations.
- AI-Driven Drug Discovery: (30%) Eli Lilly is leveraging AI to accelerate drug discovery through partnerships.
- India Investment: (20%) Eli Lilly is expanding its manufacturing and supply chain operations in India.
Most Critical Themes:
- Market Competition: (60%) Eli Lilly faces intense competition in the weight loss drug market, particularly from Novo Nordisk.
- Mounjaro Price Increase: (40%) Concerns exist regarding the increasing price of Mounjaro, potentially impacting accessibility.
Social Dominance: 0.122%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.122%
Daily Average: 0.296%
[--] Week: 0.12% -0.113%
[--] Month: 0.165% -0.133%
[--] Months: 0.165% -0.261%
[--] Year: 0.165% -0.087%
1-Year High: 1.10% on 2025-12-15
1-Year Low: 0.139% on 2025-12-07
Market Dominance: 1.10%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 1.10%
Daily Average: 1%
1-Year High: 1.50% on 2025-03-12
1-Year Low: 0.72% on 2025-08-08
Market Cap: $932,170,985,603
Market Cap 24-Hour Time-Series Raw Data
Current Value: $932,170,985,603
Daily Average: $772,719,662,904
[--] Week: $982,516,186,504 +4.30%
[--] Month: $981,091,716,800 +5.60%
[--] Months: $981,091,716,800 +55%
[--] Year: $981,091,716,800 +29%
1-Year High: $1,044,409,866,830 on 2026-02-04
1-Year Low: $560,868,171,268 on 2025-08-08
Top Eli Lilly and Company News
Top news links shared on social in the last [--] hours
Showing a maximum of [--] news posts without a LunarCrush subscription.
"Lilly's Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase [--] LIBRETTO-432 clinical trial of Retevmo"
News Link @PRNewswire 2026-02-16T12:25Z 120.9K followers, 15.4K engagements
"Lilly Strikes Deal for Orna Therapeutics for Up to $2.4 Billion - Bloomberg Eli Lilly & Co agreed to buy closely held US biotech Orna Therapeutics Inc. for up $2.4 billion in cash its second deal in as many days as the company expands its pipeline beyond its well-known blockbuster obesity drug Zepbound"
News Link @business 2026-02-09T12:18Z 9.8M followers, 17.5K engagements
"Eli Lilly's weight loss drug retatrutide clears first late-stage study The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill"
News Link @CNBCi 2025-12-11T11:51Z 181.9K followers, 28.8K engagements
Top Eli Lilly and Company Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"How to Invest in Ozempic Stock: NVO LLY OZEM THNR and More (Not Just Hype) Ozempic is everywhere right now but how do you actually invest in the company behind it without just chasing hype In this video Ryan Mack from Main Street breaks down three simple tiers: buying individual stocks like Novo Nordisk (NVO) and Eli Lilly (LLY) looking at GLP1 and weightloss ETFs like OZEM and THNR and then digging into more advanced plays in the obesitydrug space. This is short simple and designed for everyday people who want to understand the opportunity AND the risks. Before you invest in anything"
YouTube Link @ryancmack 2026-02-16T18:42Z [----] followers, [---] engagements
"How can an UBS analyst seriously guide for [------] wegovy predictions in Q1 when it already has sold [------] in the first [--] weeks has he been sleeping under a rock Wegovy pill sales in Q1 will be far closer to [--] million scripts than [------]. Theres a fair chance it will get above [--] million scripts in Q1. Below is from today $LLY $NVO $VKTX https://twitter.com/i/web/status/2023456212268806314 https://twitter.com/i/web/status/2023456212268806314"
X Link @ResearchPulse1 2026-02-16T17:55Z [----] followers, [----] engagements
"Ive seen this setup before - float tightens then price snaps. 46.8M shares total 66% insider locked institutions scaling hard. Thats not retail noise. Thats structural pressure building in NASDAQ: NXXT $BOXL #Rashmer #BBMzansiS6 $ARCC $LLY Liquidity dries up first Then price reacts🚀 46.8M total float 66% locked by insiders Institutions absorbing shares quarter after quarter Jane Street +646% Nuveen +433% Wells +193% JPM +45% Right in the middle of this ownership shift sits NextNRG Inc. (NASDAQ: NXXT) When https://t.co/Ao7gjFv3JB Liquidity dries up first Then price reacts🚀 46.8M total float"
X Link @ClaireM0rg4n 2026-02-16T16:26Z [---] followers, [---] engagements
"Corecia se tot amn 💥 BURSELE STAU DAR BANII NU DORM President's Day Dosarele Epstein Nvidia & AI Bitcoin i Rzboiul Tarifelor Pieele americane sunt nchise azi dar lumea financiar fierbe. De la rezultatele trimestriale ale Big Tech pn la dosarele Epstein care zguduie elite globale acest episod e OBLIGATORIU dac vrei s nelegi ce urmeaz. 🧨 Ce afli n episodul de azi: Jamie Dimon pune presiune pe Fed ce nseamn asta pentru dobnzi Cine e noul guvernator al Federal Reserve i de ce conteaz Republicani vs. Trump fisuri n partid Dosarele Epstein: demisii n lan la nivel mondial Amazon Microsoft Meta"
YouTube Link @feedyourgreedofficial 2026-02-16T16:00Z 167K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing